Articles

With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.

The Next Domino: Automation, AI, and touchless safety case processing

What if you could predict potential safety issues before clinical development begins? Innovative new signal detection and management approaches have been developed to help clinical trial sponsors, manufacturers, and CROs combat safety-related challenges and provide insight to be used to predict potential safety issues even before clinical development begins. Applying those learnings to their choice of initial research candidates can ultimately mean safer medicines for patients.

Smarter Signal Management: AI, big data, and predictive analytics

This white paper describes how digitizing medicines can drive patient engagement, reduce non-adherence, and enhance supply chain visibility.

The Future of Medicine is Smart

The Impact of False Starts on Omnichannel Efforts 

What Life Sciences Companies Need to Know From Startup to Commercialization

This white paper investigates best practices and tangible benefits associated with a risk-based quality management (RBQM) approach to clinical trial management.

Analysis of Risk-Based Quality Management Approach - White Paper

Life sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.


Flip the Script

Gain actionable insights from Lash Group experts, leveraging 30+ years of experience launching new programs to help you ensure patient support success. 

All Whitepapers